Literature DB >> 12778083

Smoking and breast cancer.

P Terry, K C Johnson.   

Abstract

Entities:  

Mesh:

Year:  2003        PMID: 12778083      PMCID: PMC2741054          DOI: 10.1038/sj.bjc.6600933

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
Sir The conclusion of the Collaborative Group on Hormonal Factors in Breast Cancer (Collaborative Group on Hormonal Factors and Breast Cancer, 2002) that cigarette smoking has little or no independent effect on the risk of developing breast cancer may not be warranted. Several recent studies of breast cancer risk suggest that a positive association with smoking may emerge 30–40 years after commencement (Terry and Rohan, 2002), particularly among chronic heavy smokers. There is also evidence to suggest that smoking prior to a first full-term pregnancy may be an important exposure (Russo ; Band ; Terry and Rohan, 2002). In addition, an increasing number of studies suggest that a possitive association between smoking and breast cancer risk may be stronger among (or limited to) women with certain genotypes (Terry and Rohan, 2002). To what extent the Collaborative Group's examination of smoking as ‘ever vs never’ or ‘current vs never’ could account for such possible time-dependent or genetic associations is unclear. The possibility of an association between cigarette smoking and breast cancer risk among certain groups of women should not be ruled out based solely on the Collaborative Group's analyses.
  4 in total

1.  Carcinogenic and endocrine disrupting effects of cigarette smoke and risk of breast cancer.

Authors:  Pierre R Band; Nhu D Le; Raymond Fang; Michèle Deschamps
Journal:  Lancet       Date:  2002-10-05       Impact factor: 79.321

Review 2.  Cigarette smoking and the risk of breast cancer in women: a review of the literature.

Authors:  Paul D Terry; Thomas E Rohan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-10       Impact factor: 4.254

Review 3.  Differentiation of the mammary gland and susceptibility to carcinogenesis.

Authors:  J Russo; L K Tay; I H Russo
Journal:  Breast Cancer Res Treat       Date:  1982       Impact factor: 4.872

4.  Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease.

Authors:  N Hamajima; K Hirose; K Tajima; T Rohan; E E Calle; C W Heath; R J Coates; J M Liff; R Talamini; N Chantarakul; S Koetsawang; D Rachawat; A Morabia; L Schuman; W Stewart; M Szklo; C Bain; F Schofield; V Siskind; P Band; A J Coldman; R P Gallagher; T G Hislop; P Yang; L M Kolonel; A M Y Nomura; J Hu; K C Johnson; Y Mao; S De Sanjosé; N Lee; P Marchbanks; H W Ory; H B Peterson; H G Wilson; P A Wingo; K Ebeling; D Kunde; P Nishan; J L Hopper; G Colditz; V Gajalanski; N Martin; T Pardthaisong; S Silpisornkosol; C Theetranont; B Boosiri; S Chutivongse; P Jimakorn; P Virutamasen; C Wongsrichanalai; M Ewertz; H O Adami; L Bergkvist; C Magnusson; I Persson; J Chang-Claude; C Paul; D C G Skegg; G F S Spears; P Boyle; T Evstifeeva; J R Daling; W B Hutchinson; K Malone; E A Noonan; J L Stanford; D B Thomas; N S Weiss; E White; N Andrieu; A Brêmond; F Clavel; B Gairard; J Lansac; L Piana; R Renaud; A Izquierdo; P Viladiu; H R Cuevas; P Ontiveros; A Palet; S B Salazar; N Aristizabel; A Cuadros; L Tryggvadottir; H Tulinius; A Bachelot; M G Lê; J Peto; S Franceschi; F Lubin; B Modan; E Ron; Y Wax; G D Friedman; R A Hiatt; F Levi; T Bishop; K Kosmelj; M Primic-Zakelj; B Ravnihar; J Stare; W L Beeson; G Fraser; R D Bullbrook; J Cuzick; S W Duffy; I S Fentiman; J L Hayward; D Y Wang; A J McMichael; K McPherson; R L Hanson; M C Leske; M C Mahoney; P C Nasca; A O Varma; A L Weinstein; T R Moller; H Olsson; J Ranstam; R A Goldbohm; P A van den Brandt; R A Apelo; J Baens; J R de la Cruz; B Javier; L B Lacaya; C A Ngelangel; C La Vecchia; E Negri; E Marubini; M Ferraroni; M Gerber; S Richardson; C Segala; D Gatei; P Kenya; A Kungu; J G Mati; L A Brinton; R Hoover; C Schairer; R Spirtas; H P Lee; M A Rookus; F E van Leeuwen; J A Schoenberg; M McCredie; M D Gammon; E A Clarke; L Jones; A Neil; M Vessey; D Yeates; P Appleby; E Banks; V Beral; D Bull; B Crossley; A Goodill; J Green; C Hermon; T Key; N Langston; C Lewis; G Reeves; R Collins; R Doll; R Peto; K Mabuchi; D Preston; P Hannaford; C Kay; L Rosero-Bixby; Y T Gao; F Jin; J-M Yuan; H Y Wei; T Yun; C Zhiheng; G Berry; J Cooper Booth; T Jelihovsky; R MacLennan; R Shearman; Q-S Wang; C-J Baines; A B Miller; C Wall; E Lund; H Stalsberg; X O Shu; W Zheng; K Katsouyanni; A Trichopoulou; D Trichopoulos; A Dabancens; L Martinez; R Molina; O Salas; F E Alexander; K Anderson; A R Folsom; B S Hulka; L Bernstein; S Enger; R W Haile; A Paganini-Hill; M C Pike; R K Ross; G Ursin; M C Yu; M P Longnecker; P Newcomb; L Bergkvist; A Kalache; T M M Farley; S Holck; O Meirik
Journal:  Br J Cancer       Date:  2002-11-18       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.